NO20024893D0 - Fremgangsmåter for ansamitocin-produksjon - Google Patents

Fremgangsmåter for ansamitocin-produksjon

Info

Publication number
NO20024893D0
NO20024893D0 NO20024893A NO20024893A NO20024893D0 NO 20024893 D0 NO20024893 D0 NO 20024893D0 NO 20024893 A NO20024893 A NO 20024893A NO 20024893 A NO20024893 A NO 20024893A NO 20024893 D0 NO20024893 D0 NO 20024893D0
Authority
NO
Norway
Prior art keywords
methods
ansamitocin
production
ansamitocin production
Prior art date
Application number
NO20024893A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024893L (no
Inventor
Mark Fulston
Anna Stefanska
Jan Thirkettle
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20024893L publication Critical patent/NO20024893L/no
Publication of NO20024893D0 publication Critical patent/NO20024893D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20024893A 2000-04-12 2002-10-10 Fremgangsmåter for ansamitocin-produksjon NO20024893D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19636100P 2000-04-12 2000-04-12
PCT/GB2001/001661 WO2001077360A2 (en) 2000-04-12 2001-04-11 Methods for ansamitocin production

Publications (2)

Publication Number Publication Date
NO20024893L NO20024893L (no) 2002-10-10
NO20024893D0 true NO20024893D0 (no) 2002-10-10

Family

ID=22725075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024893A NO20024893D0 (no) 2000-04-12 2002-10-10 Fremgangsmåter for ansamitocin-produksjon

Country Status (21)

Country Link
US (2) US6573074B2 (cs)
EP (1) EP1272653B1 (cs)
JP (1) JP4832697B2 (cs)
KR (1) KR20030036159A (cs)
CN (1) CN1432068A (cs)
AR (1) AR028002A1 (cs)
AT (1) ATE331804T1 (cs)
AU (2) AU2001293335B2 (cs)
BR (1) BR0109975A (cs)
CA (1) CA2406188A1 (cs)
CZ (1) CZ20023356A3 (cs)
DE (1) DE60121150T2 (cs)
ES (1) ES2266243T3 (cs)
HU (1) HUP0300473A3 (cs)
IL (1) IL152241A0 (cs)
MX (1) MXPA02010109A (cs)
NO (1) NO20024893D0 (cs)
NZ (1) NZ521868A (cs)
PL (1) PL365577A1 (cs)
WO (1) WO2001077360A2 (cs)
ZA (1) ZA200208159B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
EP1627069A4 (en) * 2002-08-08 2010-06-02 Glaxosmithkline Llc PROCESS FOR THE ISOLATION AND PURIFICATION OF ANSAMITOCINES
US7432088B2 (en) * 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
WO2005020883A2 (en) * 2003-05-08 2005-03-10 Immunogen, Inc. Methods for the production of ansamitocins
US7276497B2 (en) * 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
WO2007067698A2 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
EP1806365A1 (en) 2006-01-05 2007-07-11 Boehringer Ingelheim International GmbH Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
CN100420754C (zh) * 2006-10-26 2008-09-24 浙江海正药业股份有限公司 一种制备蒽莎姆菌素的方法
DK3415531T3 (da) 2011-05-27 2023-09-18 Glaxo Group Ltd Bcma (cd269/tnfrsf17)-bindende proteiner
CN102505023A (zh) * 2011-11-18 2012-06-20 华东理工大学 一种dahp合酶的异源可溶性表达方法及其重组载体和基因工程菌
CN108276427A (zh) * 2018-01-14 2018-07-13 常州大学 一种安丝菌素p-3的提取与分离纯化方法
CN110117626A (zh) * 2018-02-06 2019-08-13 上海键合医药科技有限公司 一种制备安丝菌素p3的发酵工艺
PT3956332T (pt) 2019-04-18 2023-04-24 Indena Spa Processo diasterosselectivo para a preparação de ésteres de maitansinoides contendo tiol ou dissulfeto e seus intermediários
CN113444106A (zh) * 2020-03-25 2021-09-28 重庆乾泰生物医药有限公司 一种高纯度安丝菌素的制备方法
CA3220227A1 (en) 2021-05-28 2022-12-01 Matthew Bruce Combination therapies for treating cancer
CN117597450A (zh) * 2021-06-18 2024-02-23 杭州中美华东制药有限公司 安丝菌素p-3的提纯方法
WO2023057893A1 (en) 2021-10-05 2023-04-13 Glaxosmithkline Intellectual Property Development Limited Combination therapies for treating cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1314019A (en) * 1969-07-19 1973-04-18 Rolland Sa A Antibiotic substance and process for the extraction of such an antibiotic substance from a strain of pseudomonas
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
JPS6010718B2 (ja) 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル，メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
US4162940A (en) 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS6016236B2 (ja) * 1977-11-18 1985-04-24 武田薬品工業株式会社 抗生物質ｃ―１５００３ ｐ―３の製造法
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
US4423211A (en) * 1981-12-21 1983-12-27 Merck & Co., Inc. Process for the whole broth extraction of avermectin
JPH0347090A (ja) * 1988-12-27 1991-02-28 Takeda Chem Ind Ltd 二重特異性を有するハイブリッドモノクローナル抗体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
WO1991009134A1 (en) 1989-12-15 1991-06-27 Takeda Chemical Industries, Ltd. Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics
FR2656874B1 (fr) * 1990-01-11 1992-04-03 Commissariat Energie Atomique Procede de production et d'extraction d'anti-oxydants a partir d'une culture de micro-organismes et photobioreacteur pour la mise en óoeuvre de ce procede.
DE4037441A1 (de) * 1990-11-24 1992-05-27 Basf Ag Verfahren zur erhoehung des riboflavin-gahaltes in spruehgetrockneten fermenteraustraegen bei riboflavin-fermentationen
JPH08214870A (ja) * 1995-02-17 1996-08-27 Kanegafuchi Chem Ind Co Ltd ファフィア・ロドチーマ酵母の細胞壁処理方法
CN1056845C (zh) * 1995-03-03 2000-09-27 弗·哈夫曼-拉罗切有限公司 核黄素的纯化

Also Published As

Publication number Publication date
AU2001293335B2 (en) 2005-02-24
DE60121150D1 (de) 2006-08-10
PL365577A1 (en) 2005-01-10
DE60121150T2 (de) 2007-05-16
HUP0300473A3 (en) 2004-07-28
IL152241A0 (en) 2003-05-29
AU9333501A (en) 2001-10-23
ZA200208159B (en) 2003-10-17
NZ521868A (en) 2004-11-26
WO2001077360A3 (en) 2002-09-12
ES2266243T3 (es) 2007-03-01
WO2001077360A2 (en) 2001-10-18
CA2406188A1 (en) 2001-10-18
CN1432068A (zh) 2003-07-23
CZ20023356A3 (cs) 2003-04-16
KR20030036159A (ko) 2003-05-09
JP2003530114A (ja) 2003-10-14
ATE331804T1 (de) 2006-07-15
US20020015984A1 (en) 2002-02-07
AR028002A1 (es) 2003-04-23
EP1272653A2 (en) 2003-01-08
NO20024893L (no) 2002-10-10
EP1272653B1 (en) 2006-06-28
US20030157669A1 (en) 2003-08-21
US6573074B2 (en) 2003-06-03
HUP0300473A2 (hu) 2003-06-28
MXPA02010109A (es) 2003-02-12
BR0109975A (pt) 2004-03-23
JP4832697B2 (ja) 2011-12-07

Similar Documents

Publication Publication Date Title
NO20025590L (no) Fenylglycin-derivater
DE60205413D1 (de) Herstellungsverfahren
NO20026100D0 (no) Boringsmetode
DE60117286D1 (de) Prozesssteuerung
NO20030559D0 (no) Fremgangsmåte for produksjon av papir
NO20024869D0 (no) Oksygenatomdanningsprosess
NO20024893D0 (no) Fremgangsmåter for ansamitocin-produksjon
NO20010146D0 (no) Fremgangsmåte for ökning av hydrokarbonproduksjon
DE50115520D1 (de) Strahlformungsverfahren
DE60106503D1 (de) Luftreifen
DE60116941D1 (de) Luftreifen
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
DE60113311D1 (de) Luftreifen
IS6716A (is) Aðferðir við að framleiða sílostasól
DE50100418D1 (de) Brezelherstellungssystem
DE60106037T8 (de) Reifenentwurfsverfahren
DE50100739D1 (de) Drehmaschine
EP1343354A4 (en) METHOD FOR MANUFACTURING A HIGH SPEAKER
NO20022983L (no) Aminometyl-fenyl-cykloheksanonderivater
DE60103432D1 (de) Luftreifen
DE60130426D1 (de) Aluminiumoxid-Leuchtstoff- Herstellungsverfahren
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
DE60207451D1 (de) Produktionsverfahren
DE60012372D1 (de) Verbesserte herstellungsmethode für acylferrocene
ID29728A (id) Proses untuk pembuatan piridin-piridin tersubstitusi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application